跳至主要内容
临床试验/NL-OMON23615
NL-OMON23615已完成不适用

FLT PET in newly diagnosed GBM

MCGroningen0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients with histologically confirmed newly diagnosed glioblastoma multiforme
  • (World Health Organization [WHO] grade IV astrocytoma) with indication and
  • eligibility for radiotherapy and concomitant TMZ followed by adjuvant TMZ. Patients
  • must have clinically and radiographically documented measurable disease.
  • Conventional MRI post surgery must be performed within 28 days prior to start of
  • combined treatment;

排除标准

  • 1. Patients with no histologically confirmed newly diagnosed glioblastoma multiforme
  • (World Health Organization [WHO] grade IV astrocytoma) or without indication and
  • eligibility for radiotherapy and concomitant TMZ followed by adjuvant TMZ. No conventional MRI post surgery;

研究者

发起方
MCGroningen

相似试验